Welcome to this special series of the Moneyball Medicine Podcast focused on Artificial Intelligence, Machine Learning and Analytics applied to Drug Discovery and Development. This special series was recorded as part of the AI Applications Summit produced by Corey Lane Partners this October (2018) in Boston, MA. In this series I have interviewed different speakers from the event and we will hear their experiences. We will dive into the challenges and opportunities they’re facing, and their predictions for the years to come.
Part 1 of a 6-part special series. Harry interviews Andrew A. Radin, co-founder and CEO of twoXAR, an Artificial Intelligence driven drug discovery startup that unifies disparate data to identify potential disease treatments.